ES2183417T3 - Concentrado para solucion medica y su utilizacion. - Google Patents

Concentrado para solucion medica y su utilizacion.

Info

Publication number
ES2183417T3
ES2183417T3 ES98948026T ES98948026T ES2183417T3 ES 2183417 T3 ES2183417 T3 ES 2183417T3 ES 98948026 T ES98948026 T ES 98948026T ES 98948026 T ES98948026 T ES 98948026T ES 2183417 T3 ES2183417 T3 ES 2183417T3
Authority
ES
Spain
Prior art keywords
concentrated
medical solution
solution
glucose
gluconic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98948026T
Other languages
English (en)
Inventor
Torbjorn Linden
Lennart Jonsson
Stefan Knutsson
Robert Picard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gambro AB
Original Assignee
Gambro AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gambro AB filed Critical Gambro AB
Application granted granted Critical
Publication of ES2183417T3 publication Critical patent/ES2183417T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Concentrado para su uso en la preparación de una solución para infusión o una solución para uso médico destinada a hemodiálisis, hemodiafiltración, hemofiltración o diálisis peritoneal, caracterizado porque consta de ácido glucónico y glucosa y porque tiene la finalidad de ser diluida con agua o con una solución acuosa en una relación de al menos 1:150 e incluye al menos 150 g/ de glucosa y al menos 600 mmoles/l de ácido glucónico.
ES98948026T 1997-10-07 1998-10-05 Concentrado para solucion medica y su utilizacion. Expired - Lifetime ES2183417T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703650A SE510587C2 (sv) 1997-10-07 1997-10-07 Koncentrat för dialyslösning och användning därav

Publications (1)

Publication Number Publication Date
ES2183417T3 true ES2183417T3 (es) 2003-03-16

Family

ID=20408531

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98948026T Expired - Lifetime ES2183417T3 (es) 1997-10-07 1998-10-05 Concentrado para solucion medica y su utilizacion.

Country Status (9)

Country Link
US (1) US6323182B1 (es)
EP (1) EP1033984B1 (es)
JP (1) JP4346818B2 (es)
AT (1) ATE227985T1 (es)
AU (1) AU9468998A (es)
DE (1) DE69809587T2 (es)
ES (1) ES2183417T3 (es)
SE (1) SE510587C2 (es)
WO (1) WO1999017762A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8105258B2 (en) 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US7186420B2 (en) 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
ATE405277T1 (de) 1999-04-26 2008-09-15 Edwards Lifesciences Ag Substitutions-infusionflüssigkeit und zitratanticoagulation
US7445801B2 (en) * 2002-06-07 2008-11-04 Baxter International Inc. Stable bicarbonate-based solution in a single container
GR1004476B (el) * 2002-12-12 2004-03-05 Ιπποκρατης Αλεξανδρου Γιατζιδης Γλουκονικο οξυ. ενας νεος ισχυρος και ακινδυνος δεσμευτης για τη διορθωση της υπερφωσφαταιμιας των αρρωστων με τελικη νεφρικη ανεπαρκεια
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
US20050276868A1 (en) * 2004-06-10 2005-12-15 Bart Degreve Bicarbonate-based peritoneal dialysis solutions
US20100247694A1 (en) * 2008-01-31 2010-09-30 Joseph Di Bartolomeo Composition and method for treament of inflamation and infections of the outer ear canal, nose and paranasal sinuses
US20100051552A1 (en) 2008-08-28 2010-03-04 Baxter International Inc. In-line sensors for dialysis applications
DE102010039489A1 (de) * 2010-08-18 2012-02-23 Fresenius Medical Care Deutschland Gmbh Konzentrat
JP5282923B2 (ja) * 2011-12-06 2013-09-04 富田製薬株式会社 重炭酸透析剤
KR20200004341A (ko) * 2017-05-05 2020-01-13 프레제니우스 메디칼 케어 도이칠란드 게엠베하 복막 투석 농축물, 복막 투석 백 및 지속 외래 복막 투석용 또는 자동 복막 투석용 세트
CN114460202A (zh) * 2022-02-11 2022-05-10 山东威高肾科医疗器械有限公司 一种血液透析液中葡萄糖浓度的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784495A (en) 1987-02-06 1988-11-15 Gambro Ab System for preparing a fluid intended for a medical procedure by mixing at least one concentrate in powder form with water
ATE105712T1 (de) 1990-01-12 1994-06-15 Nephro Medica Pharma Bicarbonat und calcium enthaltende infusions- und dialysierlösung.
DK0510687T3 (da) 1991-04-26 2003-02-17 Mitsubishi Pharma Corp Infusionspræparation
ES2149793T5 (es) 1993-02-19 2005-03-01 Wilfried Dr.-Ing. Schal Procedimiento para la preparacion de liquido dializador bicarbonatado para la hemodialisis.
IT1263967B (it) 1993-02-24 1996-09-05 Soluzioni per dialisi peritoneale
KR960000223A (ko) 1994-06-08 1996-01-25 김정순 신규한 피리돈 카르복실산 화합물을 함유한 수용액 및 이의 제조방법
DE19631124A1 (de) 1996-08-01 1998-02-05 Fresenius Medical Care De Gmbh Verfahren zur Herstellung einer Bicarbonat enthaltenden Infusions- oder Dialysierlösung

Also Published As

Publication number Publication date
EP1033984A1 (en) 2000-09-13
SE510587C2 (sv) 1999-06-07
SE9703650D0 (sv) 1997-10-07
JP4346818B2 (ja) 2009-10-21
ATE227985T1 (de) 2002-12-15
WO1999017762A1 (en) 1999-04-15
DE69809587D1 (de) 2003-01-02
JP2001518497A (ja) 2001-10-16
DE69809587T2 (de) 2003-03-27
AU9468998A (en) 1999-04-27
US6323182B1 (en) 2001-11-27
EP1033984B1 (en) 2002-11-20
SE9703650L (sv) 1999-04-08

Similar Documents

Publication Publication Date Title
DE69522878T2 (de) Gerät für eine oszillierend, in form einer tide gepulsten peritonealdialyse
ATE294597T1 (de) Lösung für die peritonealdialyse
ES2183417T3 (es) Concentrado para solucion medica y su utilizacion.
TR199500780A2 (tr) Biyokimyasal olarak dengelenmis peritonal diyaliz solüsyonlari.
DE59003505D1 (de) Natriumbicarbonat enthaltendes wässriges Konzentrat und Zweikammerbeutelsystem zur Herstellung einer für die CAPD einsetzbaren Dialysierflüssigkeit.
ATE80548T1 (de) Medizinischer fluessigkeitsbehaelter und dessen herstellung.
IE821162L (en) Dialysis solution
TR199802547T2 (xx) Kullan�mdan sonra at�labilen hemodiyafiltrasyon seti.
HK1046090A1 (en) Use of l-carnitine and its alkanoyl derivatives asosmotic agents in solutions for medical use
BR9713653B1 (pt) composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço farmacÊutica, e, uso de pirofosfato fÉrrico.
DE3372711D1 (en) A tube set intended for extracorporeal treatment of blood and similar perishable liquids
ATE316384T1 (de) Neue dialysemethode
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
JPH0461542U (es)
TH49391A (th) การใช้ l- คาร์นิทีน และอนุพันธ์แอลคาโนอิลของมันเป็นสารออสโมทิคในสารละลายสำหรับการใช้ในทางการแพทย์
MX9600734A (es) Soluciones de dialisis peritoneal bioquimicamente balanceadas.